Menu
Serum Institute seeks DCGI nod for clinical trials of...
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has...
UAE authorises emergency use of Russia's Sputnik V vaccine...
Abu Dhabi [UAE], January 21 (ANI/Sputnik): The United Arab Emirates (UAE) authorized emergency use of Russia's...
RML Resident Doctors' Association opposes Bharat Biotech's...
New Delhi [India] January 16 (ANI): As India started its vaccination drive against COVID-19 on Saturday, members...
Russian COVID vaccine Sputnik V meets primary safety endpoint...
Hyderabad (Telangana) [India], January 11 (ANI): The Russian made Covid-19 vaccine Sputnik V has met the primary...
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin...
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced...
Emergency use of vaccine is based on safety, immunogenicity...
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on...
Bharat Biotech MD questions experts' silence over UK trials...
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's...
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for...
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved...
COVID-19: Bharat Biotech recruits 23,000 volunteers for...
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase...
Government could evaluate AstraZeneca, Covaxin: Dr Vijay Bhaskar
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the...
US launches Phase 3 trial of 2 new antibody treatments for...
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two...
Peru authorizes resumption of clinical trials of Sinopharm vaccine
Lima [Peru], December 18 (ANI/Xinhua): The Peruvian government has authorized the resumption of clinical trials of a...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.